title: A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor.
abstract: Synovial fluid cells from joints of rheumatoid arthritis (RA) patients express a novel variant of CD44 (designated CD44vRA), encoding an extra trinucleotide (CAG) transcribed from intronic sequences flanking a variant exon. The CD44vRA mutant was detected in 23 out of 30 RA patients. CD44-negative Namalwa cells transfected with CD44vRA cDNA or with CD44v3-v10 (CD44vRA wild type) cDNA bound FGF-2 to an equal extent via their associated heparan sulfate chains. However, Namalwa cells, immobilizing FGF-2 via their cell surface CD44vRA, bound substantially more soluble FGF receptor-1 (FGFR-1) than did Namalwa cells immobilizing the same amount of FGF-2 via their cell surface CD44v3-v10. The former cells stimulated the proliferation of BaF-32 cells, bearing FGFR-1, more efficiently than did the latter cells. Finally, isolated primary synovial fluid cells from RA patients expressing CD44vRA bound more soluble FGFR-1 to their cell surface-associated FGF-2 than did corresponding synovial cells expressing CD44v3-v10 or synovial cells from osteoarthritis patients. The binding of soluble FGFR-1 to RA synovial cells could be specifically reduced by their preincubation with Ab's against the v3 exon product of CD44. Hence, FGF-2 attached to the heparan sulfate moiety expressed by the novel CD44 variant of RA synovium cells exhibits an augmented ability to stimulate FGFR-1-mediated activities. A similar mechanism may foster the destructive inflammatory cascade not only in RA, but also in other autoimmune diseases.
authors.affiliation: The Lautenberg Center for General and Tumor Immunology, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.
authors.forename: Shlomo
authors.initials: S
authors.lastname: Nedvetzki
authors.forename: Itshak
authors.initials: I
authors.lastname: Golan
authors.forename: Nathalie
authors.initials: N
authors.lastname: Assayag
authors.forename: Erez
authors.initials: E
authors.lastname: Gonen
authors.forename: Dan
authors.initials: D
authors.lastname: Caspi
authors.forename: Micha
authors.initials: M
authors.lastname: Gladnikoff
authors.forename: Avner
authors.initials: A
authors.lastname: Yayon
authors.forename: David
authors.initials: D
authors.lastname: Naor
mesh_terms: D001172:Arthritis, Rheumatoid / Q000276:immunology*; D002455:Cell Division; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D006801:Humans; D018960:Hyaluronan Receptors / Q000235:genetics*; D009154:Mutation; D020033:Protein Isoforms; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D051496:Receptor, Fibroblast Growth Factor, Type 1; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism*; D013582:Synovial Fluid / Q000166:cytology
chemical_list: D018960:Hyaluronan Receptors; D020033:Protein Isoforms; D017468:Receptors, Fibroblast Growth Factor; D016222:Fibroblast Growth Factor 2; C496348:FGFR1 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D051496:Receptor, Fibroblast Growth Factor, Type 1